Psychedelic Medicine: A Field Trip with Ronan Levy


Manage episode 337120712 series 2911227
Player FM과 저희 커뮤니티의 Tatiana Irvine and Beth Weinstein 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.

Believing that you should never hesitate to trade your cow for a handful of magic beans, Ronan has built a career out of doing things that others say cannot be done. Ronan started his career as a securities lawyer at Blake, Cassels & Graydon LLP but left that after realizing he was much too creative for the profession of law. Since then, Ronan has helped launch businesses across a number of industries from gold, to cannabis, and, most recently, in psychedelics where he is a Co-founder and the Executive Chairman of Field Trip Health Ltd. (NASDAQ: FTRP, TSX: FTRP), a global leader in the development and delivery of psychedelic therapies. When not being thoroughly incorrigible, Ronan lives in Toronto with his wife and two children.

In this episode, Ronan Levy and Beth Weinstein discuss …

▶ The gray zone between perception and reality when it comes to opportunity in business
▶ The embodied empathy psychedelic experiences can give you
▶ “Ordinary Trip”, Ronan’s documentary film currently in production
▶ Field Trip’s drug development division which is researching and developing new molecules
▶ Field Trip’s at-home ketamine offering
▶ How psychedelics can help you wake up to what makes you feel good
▶ Is ketamine the next prozac?
▶ Intent, insight and integration as the core components of therapeutic psychedelic use
▶ How psychedelic therapies could become a part of a healthier lifestyle
▶ How anxiety and depression tend to creep back in several months after a series of ketamine treatments
▶ Field Trip’s “Trip” app
▶ The future of accessibility of psychedelic treatments given the current high expense
▶ How a regulated environment minimizes risk but increases cost
▶ Field Trip’s intention to be “molecule agnostic” as legalization expands
▶ 4HODIPT, a shorter acting psychedelic that has similarities to psilocybin
▶ Challenges that publicly traded psychedelic companies face
▶ The future of the legal psychedelic industry

Ronan Levy’s Links & Resources

▶ Website:
▶ Twitter:
▶ Twitter:

102 에피소드